Aurinia Pharmaceuticals Inc (AUPH) Historical Volatility

Tracking AUPH historical volatility helps you see how much Aurinia Pharmaceuticals Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Aurinia Pharmaceuticals Inc's HV tells you what really happened. Use our scanner to monitor AUPH 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The AUPH 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Aurinia Pharmaceuticals Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Aurinia Pharmaceuticals Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where AUPH HV is running hot, cold, or in line. Make the AUPH 30 day historical volatility — and every other window — work for your edge instead of against it.